Villamor, Orle A.

HRN: 17-92-62  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2025
CEFAZOLIN 1GM (VIAL)
01/23/2025
01/23/2025
IV
1g
Single Dose
Removal Of Implant
Waiting Final Action 
01/21/2025
CEFUROXIME 1.5GM (VIAL)
01/21/2025
01/28/2025
IV
1.5gm As LD Then 750mg
Q8
SP ORIF
Rejected 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: